Procter & Gamble Health Schedules Board Meeting on 2nd Nov'26 to Consider Q2 Results
Procter & Gamble Health Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
Procter & Gamble Health Schedules Board Meeting on 2nd Nov'26 to Consider Q2 Results Procter & Gamble Health Limited announced that its Board of Directors is scheduled to meet on 2nd Nov'26. The board will, inter alia, consider and approve the company's unaudited financial results for the quarter and half year ended 30th Sep'26, in compliance with Regulation 29 of the SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Procter & Gamble Health Ltd
- Stock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization. 路 17 Nov 2026
- Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA) 路 13 Nov 2026
- Press release for the unaudited financial results for the quarter ended September 30, 2026. 路 02 Nov 2026
- Outcome of Board Meeting for the Quarter Ended September 30, 2026 路 02 Nov 2026
- Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Outcome of the Board Meeting for the Quarter and half year ended September 30 , 2026. 路 02 Nov 2026
- PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 02 Nov 2026
